HQY Stock Recent News

HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.

HealthEquity Inc NASDAQ: HQY is one of the nation's largest providers of health savings accounts (HSA) and consumer-directed benefits (CDB) services. Its platform enables individuals to open, transfer, and conveniently manage HSAs and businesses to administer them seamlessly.

HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the first quarter of fiscal 2025.

HealthEquity is breaking out to a multiyear high early Tuesday after posting better-than-expected earnings, helped by the Fed's higher-for-longer interest rate policy.

HealthEquity, Inc. (NASDAQ:HQY ) Q1 2025 Earnings Conference Call June 3, 2024 4:30 PM ET Company Participants Richard Putnam - Investor Relations Jon Kessler - President & Chief Executive Officer James Lucania - Executive Vice President & Chief Financial Officer Steve Neeleman - Vice Chair and Founder Conference Call Participants Glen Santangelo - Jefferies Allen Lutz - Bank of America Greg Peters - Raymond James George Hill - Deutsche Bank Stan Berenshteyn - Wells Fargo Securities David Larsen - BTIG Stephanie Davis - Barclays Mark Marcon - Baird Jack Wallace - Guggenheim Constantine Davides - JMP Operator Good afternoon, and welcome to the HealthEquity First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HealthEquity (HQY) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.50 per share a year ago.

Highlights of the first quarter include: Revenue of $287.6 million, an increase of 18% compared to $244.4 million in Q1 FY24. Net income of $28.8 million, compared to $4.1 million in Q1 FY24, with non-GAAP net income of $70.3 million, an increase of 64% compared to $42.8 million in Q1 FY24.

Continued strength in HSA, aided by transfers of HSA Assets from BenefitWallet, is likely to have boosted HealthEquity's (HQY) top line in the fiscal first quarter.

Besides Wall Street's top -and-bottom-line estimates for HealthEquity (HQY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended April 2024.